Recent Insider Transactions - CRISPR Therapeutics (NASDAQ: CRSP)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CRSP CRISPR Therapeutics

Kulkarni Samarth / director, officer: Chief Executive Officer

10/03/2025

Buy

$67.74

49,500

$3.353M

49,500

NASDAQ CRSP CRISPR Therapeutics

Patel Naimish / officer: Chief Medical Officer

10/03/2025

Buy

$67.74

16,500

$1.118M

16,500

NASDAQ CRSP CRISPR Therapeutics

KASINGER JAMES R. / officer: General Counsel and Secretary

10/03/2025

Buy

$67.74

16,500

$1.118M

16,500

NASDAQ CRSP CRISPR Therapeutics

Prasad Raju / officer: Chief Financial Officer

10/03/2025

Buy

$67.74

16,500

$1.118M

16,500

NASDAQ CRSP CRISPR Therapeutics

Kulkarni Samarth / director, officer: Chief Executive Officer

08/18/2025

Sell

$58.15

13,081

$761K

207,004